GCM
RCPI

Goldman Capital Management’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Goldman Capital Management’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-26,440
Closed -$1.65M – 33
2015
Q1 		$1.65M Sell
26,440
-23,640
-47% -$93.1K 0.97% 17
2014
Q4 		$226K Sell
50,080
-169,340
-77% -$891K 0.12% 30
2014
Q3 		$1.54M Sell
219,420
-4,604
-2% -$45.5K 0.77% 20
2014
Q2 		$3.3M Buy
+224,024
New +$3.89M 1.64% 14

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
TC
Talkot Capital Sausalito, California $73.7M AUM 8.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Goldman Capital Management's RCPI Position: Q2 2015 in Review

Goldman Capital Management sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q2 2015, closing a stake of 26,440 shares — an estimated $1.65M sold.

Goldman Capital Management first reported a position in RCPI in Q2 2014 and held it in 4 quarters. The position peaked at $3.3M in Q2 2014. 36 funds tracked by Wall St. Rank hold RCPI as of Q2 2015.

  • Goldman Capital Management reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Goldman Capital Management sold 26,440 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q2 2015, an estimated $1.65M.
  • Goldman Capital Management first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2014 and held it in 4 quarters.
  • Goldman Capital Management's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $3.3M in Q2 2014.
  • 36 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q2 2015.

Based on Goldman Capital Management's 13F filing for Q2 2015, filed 30 Jul 2015.